Sort
130,381 grants matching “hiv”
Phone app for grounding (de-escalation) of substance-abusing transition-age youth
$809,241Lisa M Najavits · Treatment Innovations, Llc · R44 · FY2017 · AA
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
$809,131Albert C Shaw · Yale University · R01 · FY2019 · AG
Open-Source Toolkit for Knowledge-Based Querying of Time-Oriented Data
$809,109Amarendra K. Das · Stanford University · R01 · FY2010 · LM
PEDIATRICS AIDS CLINICAL TRIALS GROUP
$809,086Columbia University Health Sciences · U01 · FY2003 · AI
Ending the HIV Epidemic with Equity: An All-facility Intervention to Reduce Structural Racism and Discrimination and Its Impact on Patient and Healthcare Staff Wellbeing
$809,070Corina Lelutiu-Weinberger · Columbia University Health Sciences · R01 · FY2023 · NR
SUPPORTING THE SCALE-UP HIGH QUALITY HIV CARE AND TREATMENT PROGRAMS IN MALAWI
$808,885Dr. Steve Kamiza · University Of Malawi · U2G · FY2012 · PS
Understanding and Improving Adherence in HIV Disease
$808,862Tufts Medical Center · R01 · FY2004 · DA
Novel pediatric neurocognitive screening using central auditory tests
$808,852Jay C Buckey · Dartmouth College · R01 · FY2018 · HD
RNA modification and innate immune activation in HIV infection
$808,844Hisashi Akiyama · Boston University Medical Campus · R01 · FY2025 · AI
Pathophysiology of Metabolically Detrimental Changes in Adipose Distribution, Adipocyte Function, and Adipose Immune Environment on Antiretroviral Therapy
$808,810John Koethe · Vanderbilt University Medical Center · R01 · FY2024 · DK
Measuring Caregiver Networks of Older Adults with Alzheimer's Disease
$808,808Lee A Lindquist · Northwestern University At Chicago · R01 · FY2023 · AG
Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses
$808,787James A Hoxie · University Of Pennsylvania · R01 · FY2017 · AI
Effects of polydrug use, adulterants and HIV on cardiac injury in homeless women
$808,767Elise D Riley · University Of California, San Francisco · R01 · FY2017 · DA
Molecular effects of cannabinoids on the Blood Brain Barrier in HIV-infected brain
$808,747Maria Cecilia Garibaldi Marcondes · San Diego Biomedical Research Institute · R01 · FY2025 · DA
Trial of Vitamins in HIV Progression and Transmission
$808,688Harvard University (Sch Of Public Hlth) · R01 · FY2005 · HD
Protective Human Monoclonal Antibodies to HIV-1
$808,654Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2011 · HL
Cellular Immune Responses and AIDS Pathogenesis
$808,621Emory University · R01 · FY2003 · AI
Core 1: Non-human primate core
$808,571Guido Silvestri · Duke University · P01 · FY2018 · AI
AAV-delivered HIV inhibitors for SHIV therapy
$808,489Matthew Ryan Gardner · Emory University · R01 · FY2024 · DA
Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs
$808,479Angela D Kashuba · Univ Of North Carolina Chapel Hill · R01 · FY2014 · AI
Mechanisms of innate immune dysfunction in SIV/malaria co-infection in pregnancy
$808,466Jennifer Manuzak · Tulane University Of Louisiana · R01 · FY2023 · HD
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$808,450Mark Hatherill · University Of Cape Town · R01 · FY2021 · AI
PS04-012. HIV PREVENTION PROJECTS
$808,407Bronwen Anderson · Wyoming State Department Of Health · U62 · FY2008 · PS
A dyad approach to combination HIV prevention in pregnancy for Zambia and Malawi
$808,406Benjamin H Chi · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers: A Stepped Wedge Hybrid Type II Effectiveness Implementation Trial
$808,388Florence M Momplaisir · University Of Pennsylvania · R01 · FY2020 · NR